Early animal model studies have confirmed that aldosterone, as an MR agonist, promotes vascular inflammatory cell infiltration, myocardial interstitial fibrosis, and ventricular remodeling (48–52), which further leads to myocardial, aortic fibrosis, and renal sclerosis. Here, NR3C2 is linked to nephrosclerosis.